Skip to main content
Netherlands News in English

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Image
A hospital isolation room
A hospital isolation room - Credit: sudok1 / DepositPhotos - License: DepositPhotos
Health
Amsterdam UMC
Covid-19
SARS-CoV-2
Coronavirus
Omicron variant
persistent infection
immunocompromised
mutation
virus mutation
public health
Monday, 22 April 2024 - 10:07

Share this article:

Dutchman had coronavirus for 613 days; Virus mutated over 50 times in his body

A Dutch man was infected with the coronavirus for 613 days, researchers from the Amsterdam UMC report. ​​”To the authors' knowledge, it is the longest SARS-CoV-2 infection duration to date.” The virus muted over 50 times in his body.

The 72-year-old immunocompromised man continuously tested positive for SARS-CoV-2 from his admission to an Amsterdam clinic in February 2022 until he died of an underlying condition in October 2023. He initially became infected with the Omnicron variant of the coronavirus, but the virus mutated over 50 times in his body. As far as the researchers know, he did not infect anyone else with his mutated form of the virus.

Such persistent coronavirus infections are rare, but several cases of infections lasting hundreds of days in immunocompromised patients have been reported. Researchers worry that these persistent infections could lead to more mutations in the coronavirus. “For instance, it is thought that the initial emergence of the Omicron variant originated in an immunocompromised individual, highlighting the importance of close genomic surveillance in this patient population.” Not all mutations may be as manageable as the Omicron variant.

“We emphasize the importance of continuing genomic surveillance of SARS-CoV-2 evolution in immunocompromised individuals with persistent infections given the potential public health threat of possibly introducing viral escape variants into the community,” the researchers said. They stressed that there must be a balance between this surveillance and “human supportive care” for the patients involved.

The researchers also stressed that “from the viewpoint of the general public, prolonged infections remain rare as the immunocompromised population is only a very small percentage of the total population.”

The Amsterdam researchers will present their findings at the ESCMID medical congress in Barcelona between April 27 and 31.

More like this

Image
A healthworker looking through a window in Hospital during the coronavirus pandemic.
Five years after first Covid-19 infection Netherlands is even less prepared for pandemic
Image
Vials of Covid-19 vaccines produced by Pfizer, Moderna and AstraZeneca. March 21, 2021
Unvaccinated were twice as likely to die from Covid as vaccinated: Nivel
Image
A coronavirus self-test kit showing a positive result in October 2021
New Covid-19 variant quickly spreading through NL; Biggest summer outbreak since 2021
Image
Vials of Covid-19 vaccines produced by Pfizer, Moderna and AstraZeneca. March 21, 2021
Dutch gov't did too little to prevent cronyism in buying Covid vaccines: Court of Audit
Make NL Times your top Google source

Follow us:

Latest stories

  • Thousands of Dutch face up to three years’ delays for higher-capacity grid connections
  • Cop claims he was unaware woman he pushed down at asylum shelter was pregnant
  • Highest Dutch business court overturns Volkswagen diesel emissions scandal fine
  • BBB Senate faction opposes conversion therapy ban despite earlier support
  • KLM cancels Uganda flights amid Ebola-related travel restrictions

Top stories

  • Football coach jailed for secretly filming over 500 boys in changing rooms
  • U.S. Embassy: Dutch World Cup fans can face long passport lines, social media checks
  • Tata Steel drops new Sustainability Chief Pols over pro-apartheid past in South Africa
  • Waiting times of a year or longer at some Dutch hospitals as doctor shortage grows
  • Video: One killed, two hurt in stabbing at Heerhugowaard business

© 2012-2026, NL Times, All rights reserved.

Footer menu

  • Change Privacy Settings
  • Privacy Policy
  • Contact
  • Partner Content